Nutex Health Inc (NASDAQ:NUTX) Emerges as a Top Growth Stock Using Louis Navellier's "Little Book" Strategy

In growth investing, few methods are as clear and established as the one in Louis Navellier’s The Little Book That Makes You Rich. The plan simplifies the hunt for leading growth stocks into eight specific rules, centered on earnings revisions, sales and earnings growth, improving profitability, and sound financial condition. This structured process seeks to find companies that are not only growing, but speeding up in a financially sound manner. A recent filter using these ideas has identified a notable prospect in the healthcare field: Nutex Health Inc (NASDAQ:NUTX).

Notable for Earnings Revisions and Surprises

Two of Navellier’s central ideas concern analyst opinion and a firm’s capacity to beat forecasts. Positive earnings revisions mean analysts are becoming more confident from new data, while repeated earnings surprises can push future estimates up. Nutex Health shows notable performance on each point.

• Earnings Revisions: The average EPS forecast for the coming quarter has increased by 43.7% in the past three months, a major upward change that points to rising analyst confidence.
• Earnings Surprises: The firm has reported a positive earnings surprise in three of the past four quarters, with an average beat of a remarkable 2,386.6%. This habit of greatly surpassing forecasts is a strong sign for growth investors.

Strong Growth in Important Measures

The center of the "Little Book" plan is finding speeding growth. Nutex Health’s recent results show strong movement in both revenue and earnings.

• Revenue Growth: Year-over-year revenue has increased by 236.0%, while the latest quarter’s sales grew 239.9% versus the same quarter last year. This matches and greatly passes the plan’s need for rising sales growth.
• Earnings Growth: The improvement in profitability is even more clear. Year-over-year EPS has risen by 873.6%, and quarterly EPS growth is 551.2%. This meets the rule for solid earnings growth and shows the firm is effectively turning its rising revenue into profit.

Improving Profitability and Solid Cash Creation

Growth is most useful when it is profitable and creates actual cash. Navellier’s rules stress widening operating margins and solid cash flow, which Nutex Health plainly displays.

• Operating Margin Improvement: The company’s operating margin has widened by a notable 278.1% over the last year. This indicates that as revenue has increased, Nutex Health has become much more efficient, retaining a bigger part of each sales dollar as operating profit.
• Free Cash Flow Growth: The essential need of any growing company is free cash flow. Nutex Health’s free cash flow has grown by a significant 3,319.3% in the past year, giving plentiful means to support future growth, reduce debt, or seek strategic options without needing outside funding.

Elevated Return on Equity and Favorable Movement

The last parts of the analysis involve efficiency and movement. A high Return on Equity (ROE) indicates a firm is creating solid profits from shareholder capital, while favorable earnings movement suggests acceleration.

• Return on Equity: With an ROE of 36.0%, Nutex Health is delivering excellent returns on shareholder equity, putting it in the leading group of its industry and meeting the plan’s need for high ROE.
• Earnings Movement: The company’s current quarterly EPS growth of 551.2% is much higher than the growth rate from the similar quarter a year prior (which was -14.7%). This favorable earnings movement is a key part of the filter and a mark of a speeding growth profile.

Basic Financial Condition and Valuation Setting

Beyond the specific filter criteria, a wider view of the company’s basic numbers is positive. According to ChartMill’s detailed Fundamental Analysis Report, Nutex Health has an overall score of 7 out of 10. The report notes its very good health score, backed by solid liquidity and solvency ratios, and its appealing valuation. The stock sells at a large discount to both its industry group and the wider S&P 500 based on P/E and Price/Forward Earnings ratios. This mix of strong growth, sound financial condition, and a low valuation is an uncommon and possibly strong combination for investors.

A Prospect for More Study

It is key to remember that filters are beginnings for study, not instructions to buy. Nutex Health’s profile is one of notable recent change, as shown by the measures above. Investors should think about the durability of such high growth rates, the company’s competitive position in the healthcare services field, and its long-term plan.

For investors looking to use Louis Navellier’s "Little Book" plan to the present market, this filter can work as a changing watchlist. You can see and adjust the filter with the newest results by using this link: Little Book That Makes You Rich Screen.

---

Disclaimer: This article is for information only and does not form financial guidance, a support, or a suggestion to buy, sell, or hold any security. Investing carries risk, including the possible loss of principal. Always do your own complete study and think about your personal financial position and risk comfort before making any investment choices.